Suchergebnisse - "Sanz, Miguel A"

PubPharm (6)

1

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

enthalten in: Cancer | 2021

von Vives, S. | Martínez-Cuadrón, D. | Bergua Burgues, J. | +31

2

A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

enthalten in: Cancer | 2021

von Vives, S. | Martínez‐Cuadrón, D. | Bergua Burgues, J. | +30

3

Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia : a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

enthalten in: Cancer | 2015

von Baron, F. | Labopin, M. | Peniket, A. | +6

4

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

enthalten in: Cancer | 2012

von Valcárcel, D. | Montesinos, P. | Sánchez-Ortega, I. | +13

5

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer : report of an international compassionate use study

enthalten in: Cancer | 2003

von Bosly, A. | Sonet, A. | Pinkerton, C. | +4

6

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer

enthalten in: Cancer | 2003

von Bosly, A. | Sonet, A. | Pinkerton, C. | +4

1
[1]